https://investor.ironwoodpharma.com/press-releases/press-release-details/2016/Ironwood-Closes-150-Million-Debt-Refinancing/default.aspx
Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.
- September 26, 2016